Li Tian

138 Tongzipo Road
Changsha, 410013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis.

Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis.

Journal: Frontiers in immunology

Published: April 09, 2026

Integrated metabolomics and genetic analyses reveal loss of protective docosahexaenoic acid as a key driver linking ultra-processed food to Crohn's disease risk.

Integrated metabolomics and genetic analyses reveal loss of protective docosahexaenoic acid as a key driver linking ultra-processed food to Crohn's disease risk.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2026

Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study.

Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study.

Journal: Alimentary pharmacology & therapeutics

Published: February 02, 2026

Does intestinal ultrasound combined with visceral adipose tissue more accurately predict primary non-response to infliximab in patients with Crohn's disease? A prospective, observational study.

Does intestinal ultrasound combined with visceral adipose tissue more accurately predict primary non-response to infliximab in patients with Crohn's disease? A prospective, observational study.

Journal: Therapeutic advances in gastroenterology

Published: December 08, 2025

A New Dawn Breaks for Refractory Oral and Ileocecal Ulcers.

A New Dawn Breaks for Refractory Oral and Ileocecal Ulcers.

Journal: Gastroenterology

Published: November 10, 2025

The impact of sex on the efficacy of anti-TNF-α therapy in Crohn's disease patients with different visceral adipose tissue levels.

The impact of sex on the efficacy of anti-TNF-α therapy in Crohn's disease patients with different visceral adipose tissue levels.

Journal: Scientific reports

Published: September 20, 2025

Dual-functional tea polyphenol-serotonin nanoparticles for integrated inflammation suppression and mucosal repair in inflammatory bowel disease.

Dual-functional tea polyphenol-serotonin nanoparticles for integrated inflammation suppression and mucosal repair in inflammatory bowel disease.

Journal: Biomaterials

Published: June 24, 2025

Diagnostic yield and safety of pancreatic cystic lesions: A comparison between EUS-FNA and EUS-FNB.

Diagnostic yield and safety of pancreatic cystic lesions: A comparison between EUS-FNA and EUS-FNB.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: June 16, 2025

Machine learning-based prediction of response to Ustekinumab with Crohn's disease.

Machine learning-based prediction of response to Ustekinumab with Crohn's disease.

Journal: Therapeutic advances in gastroenterology

Published: May 26, 2025

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: March 11, 2025

A Win-Win Solution: Remarkable Reversal of Foot Necrosis in Ulcerative Colitis.

A Win-Win Solution: Remarkable Reversal of Foot Necrosis in Ulcerative Colitis.

Journal: Gastroenterology

Published: November 04, 2024

Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.

Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.

Journal: Cell metabolism

Published: July 30, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026